PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Clinical and Molecular Hepatology10.3350/cmh.2021.03662022283380-395Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?Myung Ji Goh, Dong Hyun Sinnhttp://e-cmh.org/upload/pdf/cmh-2021-0366.pdf, http://e-cmh.org/journal/view.php?doi=10.3350/cmh.2021.0366, http://e-cmh.org/upload/pdf/cmh-2021-0366.pdf
Gastroenterology10.1053/j.gastro.2019.03.006201915651530-1531Aspirin: Does it Have a Role for Chemoprevention of Hepatocellular Carcinoma?Patrick Marquardt, Yujin Hoshida, Amit G. Singalhttps://api.elsevier.com/content/article/PII:S0016508519325168?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0016508519325168?httpAccept=text/plain
Clinical Liver Disease10.1002/cld.56820168248-52Statins and metformin for chemoprevention of hepatocellular carcinomaJonggi Choi, Lewis R. Robertshttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcld.568, https://onlinelibrary.wiley.com/doi/full/10.1002/cld.568
Alimentary Pharmacology & Therapeutics10.1111/apt.165682021546852-853Editorial: aspirin and NSAID for chemoprevention of hepatocellular carcinoma – ready for their use? Authors' replyMark Danta, Regina Zi Hwei Tan, Ian Lockart, Christina Abdel Shaheedhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.16568, https://onlinelibrary.wiley.com/doi/full-xml/10.1111/apt.16568, https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.16568
Alimentary Pharmacology & Therapeutics10.1111/apt.165562021546850-851Editorial: aspirin and NSAID for chemoprevention of hepatocellular carcinoma—ready for their use?Leonardo Gomes Da Fonseca, Alejandro Fornerhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.16556, https://onlinelibrary.wiley.com/doi/full-xml/10.1111/apt.16556, https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.16556
Bioscience Reports10.1042/bsr202002322020404Statin use and the prognosis of patients with hepatocellular carcinoma: a meta-analysisXiaofei Li, Liwen Liu, Yongtao Huhttps://portlandpress.com/bioscirep/article-pdf/doi/10.1042/BSR20200232/871171/bsr-2020-0232.pdf, https://portlandpress.com/bioscirep/article-pdf/doi/10.1042/BSR20200232/871171/bsr-2020-0232.pdf
Hepatology10.1002/hep.326742022766Letter to the editor: Aspirin use and the risk of hepatocellular carcinomaShih‐Wei Laihttps://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.32674, https://onlinelibrary.wiley.com/doi/full-xml/10.1002/hep.32674, https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.32674
Pharmacological Research10.1016/j.phrs.2020.1049822020159104982The risk of hepatocellular carcinoma and aspirin useKuan-Fu Liao, Yu-Hung Kuo, Shih-Wei Laihttps://api.elsevier.com/content/article/PII:S1043661820312901?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1043661820312901?httpAccept=text/plain
Liver Transplantation10.1002/lt.221032010168925-929Hepatocellular carcinoma: Ablate and wait versus rapid transplantationJohn P. Roberts, Alan Venook, Robert Kerlan, Francis Yaohttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Flt.22103, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Flt.22103, http://onlinelibrary.wiley.com/wol1/doi/10.1002/lt.22103/fullpdf
Journal of Gastroenterology and Hepatology10.1111/j.1440-1746.2012.07232.x201227111654-1664Potential for statins in the chemoprevention and management of hepatocellular carcinomaAmedeo Lonardo, Paola Loriahttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1440-1746.2012.07232.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1746.2012.07232.x/fullpdf